Copyright
©The Author(s) 2019.
World J Clin Cases. Jun 6, 2019; 7(11): 1270-1281
Published online Jun 6, 2019. doi: 10.12998/wjcc.v7.i11.1270
Published online Jun 6, 2019. doi: 10.12998/wjcc.v7.i11.1270
Variable | Crude | Adjusted1 | ||||
HR | 95%CI | P value | HR | 95%CI | P value | |
CKD patients | ||||||
Uninfected | 1.00 | Reference | 1.00 | Reference | ||
Treated | 0.31 | 0.13-0.77 | 0.011 | 0.34 | 0.14-0.84 | 0.019 |
Untreated | 1.25 | 1.00-1.56 | 0.046 | 1.28 | 1.03-1.60 | 0.029 |
Sex, men/women | 1.11 | 0.89-1.38 | 0.35 | 1.23 | 0.99-1.55 | 0.07 |
Age, per year | 1.01 | 1.00-1.01 | 0.15 | 0.99 | 0.98-0.99 | 0.006 |
Comorbidity, yes/no | ||||||
Diabetes | 2.87 | 2.28-3.61 | < 0.001 | 3.06 | 2.37-3.95 | < 0.001 |
Hypertension | 3.08 | 2.37-4.01 | < 0.001 | 3.51 | 2.57-4.79 | < 0.001 |
Coronary heart disease | 1.28 | 1.02-1.59 | 0.031 | 0.92 | 0.72-1.16 | 0.46 |
Hyperlipidemia | 1.29 | 1.04-1.60 | 0.023 | 0.85 | 0.68-1.07 | 0.16 |
Cirrhosis | 0.62 | 0.46-0.83 | 0.001 | 0.61 | 0.44-0.84 | 0.003 |
ACEI/ARB, yes/no | 1.38 | 0.65-2.92 | 0.40 | 0.96 | 0.46-2.04 | 0.92 |
Enrollee category | ||||||
1 | 1.00 | Reference | 1.00 | Reference | ||
2 | 0.68 | 0.21-2.14) | 0.50 | 0.56 | 0.17-1.80 | 0.33 |
3 | 1.26 | 0.97-1.64 | 0.08 | 1.24 | 0.95-1.63 | 0.11 |
4 | 1.47 | 1.09-1.99 | 0.012 | 1.40 | 1.03-1.92 | 0.03 |
Number of medical visits | 1.00 | 1.00-1.01 | 0.36 | 1.00 | 0.99-1.00 | 0.41 |
Charlson comorbidity index score | 1.01 | 00.98-1.04 | 0.46 | 0.93 | 0.89-0.98 | 0.008 |
- Citation: Chen YC, Li CY, Tsai SJ, Chen YC. Anti-hepatitis C virus therapy in chronic kidney disease patients improves long-term renal and patient survivals. World J Clin Cases 2019; 7(11): 1270-1281
- URL: https://www.wjgnet.com/2307-8960/full/v7/i11/1270.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i11.1270